Medication info
Ezetimibe Tablet (Ezetimibe)

Ezetimibe Tablet (Ezetimibe)

Prescription medicationTablet
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White to almost white oblong tablets
Packaging
30 tablets/box [(10 tablets/PTP*3)]
Approval status
Active

MFDS item code 201902916 · Approved 2019.05.08 · Insurance code 694004000

Summary

Main use
Improvement of hypercholesterolemia, mixed hyperlipidemia, and sitosterolemia
Who uses it
Adults
Adult dosage
Continue a standard cholesterol-lowering diet during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate this medicine concomitantly with the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). 1. Use in patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). 2. Use in patients with renal failure No dosage adjustment is required in patients with renal failure. 3. Use in elderly patients No dosage adjustment is required in elderly patients. 4. Concomitant use with bile acid sequestrants Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed hyperlipidemia, and sitosterolemia

  • Primary hypercholesterolemia
  • elevated total cholesterol
  • low-density lipoprotein cholesterol
  • apolipoprotein B
  • mixed hyperlipidemia
  • non-high-density lipoprotein cholesterol
  • homozygous familial hypercholesterolemia
  • homozygous familial sitosterolemia
  • elevated sitosterol
  • campesterol
View approved original text

This drug is primarily used as a dietary supplement to lower cholesterol levels in patients with primary hypercholesterolemia and mixed hyperlipidemia. It is particularly effective in reducing total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (Apo B). For patients with homozygous familial hypercholesterolemia, it may be used in conjunction with other lipid-lowering treatments or as an adjunct therapy, and it also helps reduce elevated sitosterol levels in patients with homozygous sitosterolemia. It should be used alongside an appropriate diet, and secondary causes of dyslipidemia should be ruled out and treated if necessary before administration. It is essential to monitor the patient's lipid levels regularly during treatment. Consequently, it is used to improve hypercholesterolemia and related lipid disorders.

Dosage and Administration

Adult dosage

Continue a standard cholesterol-lowering diet during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, with or without food. When administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate this medicine concomitantly with the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). 1. Use in patients with hepatic impairment No dosage adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). 2. Use in patients with renal failure No dosage adjustment is required in patients with renal failure. 3. Use in elderly patients No dosage adjustment is required in elderly patients. 4. Concomitant use with bile acid sequestrants Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Precautions

This drug should not be used in patients who are allergic to specific components. Patients with active liver disease or persistently elevated liver enzyme levels should not take this drug along with specific lipid-lowering agents. Caution is required for pregnant or nursing women, as the use of this drug with certain lipid-lowering agents is prohibited. Patients with moderate to severe liver impairment should avoid using this drug and should undergo regular liver function tests. If symptoms such as myalgia or muscle weakness occur, the physician should be informed immediately, and care must be taken for muscle-related adverse reactions. Patients with impaired kidney function should also be cautious when taking this drug, and dosage adjustment or monitoring may be necessary. Drug interactions may occur when combined with other medications, especially anticoagulants, immunosuppressants, and lipid-lowering agents. The use of this drug in special populations such as children, the elderly, pregnant women, and nursing mothers should be restricted or carefully considered. In the case of overdose, there is no specific treatment, so immediate consultation with medical personnel is crucial, and general supportive therapy is essential. This drug should be stored out of reach of children, and changing containers should be avoided.

Side effects

Fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, joint pain, low back pain, cough, chest pain, dizziness, headache, constipation, bloating, nausea, elevated AST, elevated ALT, myalgia, myopathy, rhabdomyolysis, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, pancreatitis, sensory disturbances, depression, cholelithiasis, cholecystitis, skin and mucous membrane syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms accompanied drug reaction, erythema multiforme, drug-induced liver damage, chest discomfort, swelling, asthenia, systemic edema, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, pruritus, upper respiratory infection, conjunctival congestion, kidney failure, liver dysfunction, elevated serum creatinine, elevated blood pressure, increased blood urea, elevated serum creatine phosphokinase, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

Store this drug in a tightly closed container to protect it from exposure to air and moisture. Additionally, the medication should be kept at room temperature between 1°C and 30°C, avoiding very hot or very cold environments.

Appearance and packaging

Appearance

White to almost white oblong tablets

Package unit

30 tablets/box [(10 tablets/PTP*3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.